| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |